BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 317567)

  • 1. Metabolism and toxicity of 9-beta-D-arabinofuranosyladenine in human malignant T cells and B cells in tissue culture.
    Carson DA; Kaye J; Seegmiller JE
    Adv Exp Med Biol; 1979; 122B():299-307. PubMed ID: 317567
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.
    Plunkett W; Chubb S; Alexander L; Montgomery JA
    Cancer Res; 1980 Jul; 40(7):2349-55. PubMed ID: 6966966
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of coformycin on the cytostatic activity of 9-beta-D-arabinofuranosyladenine and adenosine in mouse L5178y cells.
    Müller WE; Zahn RK; Arendes J; Maidhof A; Umezawa H
    Hoppe Seylers Z Physiol Chem; 1978 Oct; 359(10):1287-95. PubMed ID: 309844
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.
    Dow LW; Bell DE; Poulakos L; Fridland A
    Cancer Res; 1980 May; 40(5):1405-10. PubMed ID: 6245791
    [No Abstract]   [Full Text] [Related]  

  • 5. Uniqueness of deoxyribonucleotide metabolism in human malignant T cell lines.
    Carson DA; Kaye J; Matsumoto S; Seegmiller JE; Thompson L
    Adv Exp Med Biol; 1979; 122B():381-8. PubMed ID: 317570
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
    Verhoef V; Sarup J; Fridland A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
    Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of inhibition of deoxynucleotide-polymerizing enzyme activities from normal and leukemic human cells by 9-beta-D-arabinofuranosyladenine 5'-triphosphate and 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.
    Dicioccio RA; Srivastava BI
    Eur J Biochem; 1977 Oct; 79(2):411-8. PubMed ID: 303564
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of the cytostatic agent 9-alpha-D-arabinofuranosyladenine on the nucleic acid metabolism in L5178y cells.
    Müller WE; Zahn RK; Maidhof A; Beyer R; Arendes J
    Biochem Pharmacol; 1978; 27(12):1659-63. PubMed ID: 697906
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytotoxic activity of the adenine arabinoside analogs, 2'-azido- and 2'-amino-2'-deoxy-beta-D-arabinofuranosyladenine.
    Lee SH; Unger FM; Christian R; Sartorelli AC
    Biochem Pharmacol; 1979 Apr; 28(7):1267-9. PubMed ID: 444286
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW; Cheng YC; Schabel FM; Montgomery JA
    Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arabinosyl nucleosides--XXXIII. Metabolism of 9-beta-D-arabinofuranosyladenine in yeast cells.
    Schuster DK; Zahn RK; Sternbach H; Gaŝić MJ; Beyer R; Müller WE
    Biochem Pharmacol; 1980 Nov; 29(22):3081-5. PubMed ID: 7006610
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts.
    Verhoef V; Fridland A
    Cancer Res; 1985 Aug; 45(8):3646-50. PubMed ID: 2410098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
    Helland S; Ueland PM
    Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo.
    Müller WE; Maidhof A; Zahn RK; Shannon WM
    Cancer Res; 1977 Jul; 37(7 Pt 1):2282-90. PubMed ID: 301056
    [No Abstract]   [Full Text] [Related]  

  • 16. Relative cytotoxicity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosyladenine 5'-monophosphate.
    Juranka P; Chan VL
    Cancer Res; 1980 Nov; 40(11):4123-6. PubMed ID: 6162544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS; Plunkett W
    Cancer Res; 1982 Sep; 42(9):3637-41. PubMed ID: 6179604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biochemical genetic study of the role of specific nucleoside kinases in deoxyadenosine phosphorylation by cultured human cells.
    Ullman B; Levinson BB; Hershfield MS; Martin DW
    J Biol Chem; 1981 Jan; 256(2):848-52. PubMed ID: 6256370
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase.
    Plunkett W; Cohen SS
    Ann N Y Acad Sci; 1977 Mar; 284():91-102. PubMed ID: 280161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.